{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:13:17Z","timestamp":1773295997978,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2008.11.037","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T16:21:01Z","timestamp":1228494061000},"page":"6095-6101","source":"Crossref","is-referenced-by-count":17,"title":["Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine"],"prefix":"10.1016","volume":"27","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5682","key":"10.1016\/j.vaccine.2008.11.037_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.11.037_bib2","doi-asserted-by":"crossref","first-page":"C8","DOI":"10.1016\/j.vaccine.2008.04.011","article-title":"Vaccination and antigenic drift in influenza","volume":"26","author":"Boni","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2008.11.037_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0264-410X(02)00121-4","article-title":"Influenza and the work of the World Health Organization","volume":"20","author":"Kitler","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.037_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa044021","article-title":"Probable person-to-person transmission of avian influenza A (H5N1)","volume":"352","author":"Ungchusak","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.037_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/590912","article-title":"Vaccines against influenza A (H5N1): evidence of progress","volume":"198","author":"Poland","year":"2008","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2008.11.037_bib6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0264-410X(95)92777-Y","article-title":"Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein","volume":"13","author":"Slepushkin","year":"1995","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.11.037_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"issue":"23-24","key":"10.1016\/j.vaccine.2008.11.037_bib8","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.037_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.037_bib10","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"issue":"52","key":"10.1016\/j.vaccine.2008.11.037_bib11","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.037_bib12","series-title":"Influenza Virus","author":"Cottey","year":"2001"},{"issue":"16","key":"10.1016\/j.vaccine.2008.11.037_bib13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0264-410X(97)00115-1","article-title":"The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice","volume":"15","author":"Cataldo","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.037_bib14","unstructured":"Nicholson KG WR, Hay A. Textbook of influenza. Oxford: Blackwell Science Ltd.; 1998."},{"key":"10.1016\/j.vaccine.2008.11.037_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/524065","article-title":"Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies","volume":"197","author":"Andreasen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.037_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1086\/589302","article-title":"Influenza pandemics, immune cross-reactivity and pandemic control strategies","volume":"198","author":"Gioia","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.037_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.vaccine.2008.11.037_bib18","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.vaccine.2006.04.008","article-title":"Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines","volume":"24","author":"Ernst","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.037_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/viro.1998.9521","article-title":"Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues","volume":"254","author":"Nguyen","year":"1999","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.037_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3201\/eid1401.061283","article-title":"Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza","volume":"14","author":"Gioia","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.11.037_bib21","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T22:28:40Z","timestamp":1545604120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":21,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X08015818"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}